Skip to content

Mannkind MNKD Cash & Equivalents

Cash & Equivalents at other companies

Eli Lilly logo
Eli LillyLLY
$5.28B+70.8%
LQD
Liquidia CorporationLQDA
$222.79M+31.2%
Tenet Healthcare logo
Tenet HealthcareTHC
$2.97B-1.1%
Lexicon Pharmaceuticals logo
Lexicon PharmaceuticalsLXRX
$67.09M+6.7%
Mineralys Therapeutics, Inc. logo
Mineralys Therapeutics, Inc.MLYS
$1.15M-14.6%
Eton Pharmaceuticals, Inc. logo
Eton Pharmaceuticals, Inc.ETON
$19.66M+12.9%

Other financials

Income statement

See full
Revenue$90.2M+15.1%
Gross profit$82.7M+10.8%
Operating income-$1.7M-107%
Net income-$16.6M-226%
EPS (diluted)-$0.05-225%

Balance sheet

See full
Total debt$12.2M-9.4%
Total equity-$59.2M-1.0%
Total assets$744.4M+81.5%

Cash flow

See full
Operating cash flow-$5.4M+15.9%
CapEx$1.9M+470%
Free cash flow-$7.2M-8.0%

Valuation

See full
Market cap$1.19B+3.5%
Enterprise value$1.15B+3.0%
P/E228.5×
P/S3.3×-0.6×

Profitability

See full
Gross margin91.5%-2.6pp
Operating margin23.3%+3.1pp
Net margin9.3%
FCF margin13.8%

Returns & leverage

See full
Return on equity-8.8%
Debt / equity-0.2×
Current ratio1.9×-0.5×

Where this comes from

Reported directly by Mannkind in its filing.

Tagged under the XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue.

The official record: Mannkind’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →

Ask your AI about Mannkind's cash & equivalents.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Mannkind's cash & equivalents?
Mannkind (MNKD) reported cash & equivalents of $52.83M in Q1 2026.
How has Mannkind's cash & equivalents changed year-over-year?
Mannkind's cash & equivalents increased by 11.7% year-over-year, from $47.31M to $52.83M.
What is the long-term trend for Mannkind's cash & equivalents?
Over 5 years (2020 to 2025), Mannkind's cash & equivalents has grown at a 2.2% compound annual growth rate (CAGR), from $67.01M to $74.88M.
What does cash & equivalents mean?
Cash on hand plus highly liquid investments with maturities of three months or less at purchase — treasury bills, money market funds, and commercial paper.